Most Clicked StoriesMore >


Mylan CEO takes full responsibility for EpiPen price hikes

PCMA SmartBrief | Dec 02, 2016

During a Forbes health care summit, Mylan CEO Heather Bresch took full responsibility for the large price hikes on EpiPens, and reversed course on blaming pharmacy benefit managers for the price increases. Instead she said that there's "distance in the drug chain" between the price a manufacturer places on a drug and what it ends up costing consumers out-of-pocket. Forbes (12/01)


Pharma CEOs divided on large price increases

PCMA SmartBrief | Dec 02, 2016

Survey: Drugmakers are to blame for high prices, cost-sharing

PCMA SmartBrief | Dec 01, 2016

Medicare Part D shows PBMs succeed at reducing Rx costs

PCMA SmartBrief | Nov 30, 2016

HHS nominee wants to reduce government's role in health care

PCMA SmartBrief | Dec 05, 2016

Pence says no to overhauling Medicare, SS; yes to Medicaid changes

PCMA SmartBrief | Dec 06, 2016

PBM-negotiated discounts reducing global growth in drug spending

PCMA SmartBrief | Dec 06, 2016

Side effects of cancer immunotherapy threaten vital organs in some

PCMA SmartBrief | Dec 05, 2016

Report highlights financial ties between patient groups, drugmakers

PCMA SmartBrief | Dec 02, 2016

Patients picking up greater share of drug costs

PCMA SmartBrief | Nov 30, 2016


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more